These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23886138)

  • 1. Cancer preventive effects of whole cell type immunization against mice Ehrlich tumors.
    Aysan E; Bayrak OF; Aydemir E; Telci D; Sahin F; Yardimci C; Muslumanoglu M
    Asian Pac J Cancer Prev; 2013; 14(6):3515-9. PubMed ID: 23886138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
    Tsai TH; Burns RE; Scheving LE
    Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
    Ciria HC; Quevedo MS; Cabrales LB; Bruzón RP; Salas MF; Pena OG; González TR; López DS; Flores JM
    BMC Cancer; 2004 Nov; 4():87. PubMed ID: 15566572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrocortisone protects cycloheximide-challenged mice pretreated with Ehrlich ascites tumour cells or with cell-free Ehrlich ascites tumour fluid.
    Parry EW
    J Comp Pathol; 1990 Oct; 103(3):315-9. PubMed ID: 2258469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma.
    Symchych TV; Fedosova NI; Karaman ОМ; Yevstratieva LM; Potebnia HP
    Exp Oncol; 2017 Mar; 39(1):42-48. PubMed ID: 28361853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nonspecific immune stimulation with Corynebacterium parvum and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu C; Rişcă R; Daicoviciu D; Mulea R
    Morphol Embryol (Bucur); 1982; 28(1):77-83. PubMed ID: 6461826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased immunogenicity of Ehrlich ascites cells after heat treatment.
    Mondovì B; Santoro AS; Strom R; Faiola R; Fanelli AR
    Cancer; 1972 Oct; 30(4):885-8. PubMed ID: 5079432
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].
    Lobko GN; Porubova GM
    Eksp Onkol; 1989; 11(1):69-71. PubMed ID: 2466634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of mice against Ehrlich ascites tumour using a hamster-Ehrlich ascites tumour hybrid cell line.
    Watkins JF; Chen L
    Nature; 1969 Sep; 223(5210):1018-22. PubMed ID: 4309463
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective tumour cell ghosts with intact membrane markers.
    Davies II; Nicklin MG; Augustin R
    Nature; 1975 Jul; 256(5512):49-50. PubMed ID: 1094308
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors.
    Reibscheid EM; Zyngier S; Maria DA; Mistrone RJ; Sinisterra RD; Couto LG; Najjar R
    Braz J Med Biol Res; 1994 Jan; 27(1):91-4. PubMed ID: 8173534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed tumors of mice immunized against the Ehrlich ascites tumor.
    Ballif RN; Jones EL
    Cancer; 1968 Feb; 21(2):178-83. PubMed ID: 4952496
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.
    Barka T; Henderson S; van der Noen HM
    Tumour Biol; 2000; 21(3):145-52. PubMed ID: 10754465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant action of garlic sugar solution in animals immunized with Ehrlich ascites tumor cells attenuated with allicin.
    Nakata T; Fujiwara M
    Gan; 1975 Aug; 66(4):417-9. PubMed ID: 1183776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
    Kaya G; Akin C; Altuğ T; Devrim S
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):292-5. PubMed ID: 2450356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nonspecific immune stimulation with BCG and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu-Papilian C; Daicoviciu D; Mulea R; Rişcă R
    Morphol Embryol (Bucur); 1985; 31(3):217-25. PubMed ID: 2931598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.